biocare2-logo.gif Biomarkers in Cancer Medicine


BioCARE - Biomarkers in Cancer Medicine

A Strategic Research Program for Cancer at Lund and Gothenburg Universities

 

BioCARE Advanced Seminar

Organized together with The Mendelian Society and The Royal Physiographic Society in Lund on the Occasion of The Royal Physiographic and Mendelian Societies in Lund Honorary Lecture in Genetics 2014

Fusion Oncogenes in Cancer

November 13, 2014 at 10:00-16:00, Main lecture Hall, Medicon Village, Lund

The seminar is open and free of charge, but you need to register before October 30 to receive lunch. Separate invitation with instructions for registration is sent out by e-mail. Contact Kristin.Lindell@med.lu.se if you have not received the e-mail invitation.

10:00-10:10 Welcome remarks

Professor Sven Påhlman, coordinator BioCARE

 

​​10:10-11:35 The Royal Physiographic and Mendelian Societies in Lund Honorary Lectures in Genetics

 

Introduction of the 2014 Lecturers professor Felix Mitelman and professor Arul Chinnaiyan

by professors Göran Stenman and Thoas Fioretos

 

10:15-10:55

Chromosome Aberrations and Gene Fusions in Cancer. Professor Felix Mitelman, Department of Clinical Genetics, Lund University, Lund, Sweden.

 

10:55-11:35

Recurrent Gene Fusions in Solid Tumors: Implications for Precision Medicine. Professor Arul Chinnaiyan, Department of Pathology and Urology, University of Michigan Medical School, Ann Arbor, MI.

 

11:35-12:00 Treatment of chronic myeloid leukemia 13 years after the introduction of imatinib: Lessons learned from a clinical perspective. Prof. Johan Richter, Lund University.

​12:00-13:00 Lunch

 

13:00-13:30 ALK fusion oncogenes in cancer. Prof. Ruth Palmer, University of Gothenburg

 

13:30-13:50 The gene fusion landscape of childhood acute lymphoblastic leukemia. Dr Henrik Lilljebjörn, Lund University.

 

13:50-14:10 Aneuploidy versus fusion genes in childhood acute lymphoblastic leukemia. Dr. Kajsa Paulsson, Lund University.

 

14:10-14:40 Coffee break

 

14:40-15:00 Targeting the MYB-NFIB fusion oncogene in adenoid cystic carcinoma. Dr. Mattias Andersson, University of Gothenburg.

 

15:00-15:20 Regulation and properties of the FUS-DDIT3 fusion in myxoid liposarcoma. Dr. Anders Ståhlberg, University of Gothenburg.

 

15:20-15:40 Innovations in Cancer: The way forward at Lund University. Dr. Johanna Asklin, innovation manager, Lund University

 

15:40-16:00 Closing remarks

If you have any questions please contact:

Kristin Lindell or the director of the Research School Thoas Fioretos

LundUniversity_C_BLACK-Converted.gif biocare2-logo.gif LO_GU_cen2rBlack-2.png

BioCARE Lund University - Medicon Village 406 (311K2), Scheelevägen 2 - SE-223 81 Lund - +46-46-2226420

BioCARE University of Gothenburg - Cancer Center Sahlgrenska - Box 425 - 405 30 Göteborg -

Email BioCARE - www.biocare.nu

Design by Xpresso Publishing